companydata.dkNORDIC BIOTECH PRIVATE INVESTORS ApS: Financial statements 2025
CVR: 26284384
NORDIC BIOTECH PRIVATE INVESTORS ApS (CVR 26284384) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -432,293 and a net result of DKK -571,396 compared with DKK 2,080,087 the year before. Equity amounted to DKK 2,975,449. The solvency ratio was 98.3%.
- Gross Profit
- -432,293 kr.
- Profit/Loss
- -571,396 kr.
- Equity
- 2,975,449 kr.
- Total Assets
- 3,026,329 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -432 t. | -571 t. | 3 mio. | 0 |
| 2024 | - | -242 t. | 2.1 mio. | 3.5 mio. | - |
| 2023 | - | 49 t. | -8 t. | 1.5 mio. | - |
| 2022 | - | -20 t. | -1 mio. | 1.5 mio. | 0 |
| 2021 | - | -15 t. | -168 t. | 2.5 mio. | 0 |
Find more companies like NORDIC BIOTECH PRIVATE INVESTORS ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2025
NORDIC BIOTECH PRIVATE INVESTORS ApS has published its annual report for 2024. Gross profit came to DKK -242,054, and the net result was DKK 2,080,087.
About NORDIC BIOTECH PRIVATE INVESTORS ApS
NORDIC BIOTECH PRIVATE INVESTORS ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2001. The company was registered under the industry Ikke-finansielle holdingselskaber. The management consists of Jakob Mosegaard Larsen. The company's owners include Thue Walter Schwartz, Peter Moldt and Dorte Kloppenborg Skrumsager. In 2025, the company reported a gross profit of DKK -432,293 and a net result of DKK -571,396 compared with DKK 2,080,087 the year before. Equity amounted to DKK 2,975,449.